Shijiazhuang No.4 Pharmaceutical Group: Low-calcium peritoneal dialysis solution and other drugs obtain drug production registration approval
SSY Group announced that the group has obtained drug production registration approvals from China's National Medical Products Administration for low-calcium peritoneal dialysis solution, peritoneal dialysis solution, peritoneal dialysis solution, and low-calcium peritoneal dialysis solution, all in 2000ml specifications, belonging to Category 3 chemical drugs and deemed to have passed consistency evaluation, among which the low-calcium peritoneal dialysis solution is the third approved by a domestic enterprise. These products are mainly used for peritoneal dialysis in patients with chronic renal failure, and are used when hypermagnesemia has not been sufficiently improved.
Latest
16 m ago

